Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
0.6885
+0.0085 (1.25%)
Mar 31, 2025, 2:33 PM EDT - Market open

CNTB Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Jan '22 Dec '20 2019 - 2018
Revenue
26.03----
Upgrade
Gross Profit
26.03----
Upgrade
Selling, General & Admin
19.2314.5220.8119.0147.72
Upgrade
Research & Development
29.2651.9196.6380.5150.93
Upgrade
Other Operating Expenses
--1.48-1.08-1.85-6.99
Upgrade
Operating Expenses
48.4964.95116.3697.66191.66
Upgrade
Operating Income
-22.45-64.95-116.36-97.66-191.66
Upgrade
Interest Expense
--0.02-0.02-0.01-2.89
Upgrade
Interest & Investment Income
4.455.221.810.171.39
Upgrade
Currency Exchange Gain (Loss)
-0.371.47-0.52-6.77
Upgrade
Other Non Operating Income (Expenses)
2.59---103.98-579.29
Upgrade
EBT Excluding Unusual Items
-15.41-59.38-113.1-202-779.23
Upgrade
Asset Writedown
---4.7--
Upgrade
Pretax Income
-15.41-59.38-117.79-202-779.23
Upgrade
Income Tax Expense
0.220.120.30.27-
Upgrade
Earnings From Continuing Operations
-15.63-59.5-118.09-202.27-779.23
Upgrade
Net Income
-15.63-59.5-118.09-202.27-779.23
Upgrade
Net Income to Common
-15.63-59.5-118.09-202.27-779.23
Upgrade
Shares Outstanding (Basic)
5555555217
Upgrade
Shares Outstanding (Diluted)
5555555217
Upgrade
Shares Change (YoY)
0.27%0.04%5.50%205.31%1.27%
Upgrade
EPS (Basic)
-0.28-1.08-2.15-3.88-45.60
Upgrade
EPS (Diluted)
-0.28-1.08-2.15-3.88-45.60
Upgrade
Free Cash Flow
-24.36-48.22-105.93-88.16-182.12
Upgrade
Free Cash Flow Per Share
-0.44-0.88-1.92-1.69-10.66
Upgrade
Gross Margin
100.00%----
Upgrade
Operating Margin
-86.24%----
Upgrade
Profit Margin
-60.03%----
Upgrade
Free Cash Flow Margin
-93.58%----
Upgrade
EBITDA
-21.79-64.23-115.63-97.17-190.7
Upgrade
EBITDA Margin
-83.71%----
Upgrade
D&A For EBITDA
0.660.720.730.490.96
Upgrade
EBIT
-22.45-64.95-116.36-97.66-191.66
Upgrade
EBIT Margin
-86.24%----
Upgrade
Revenue as Reported
26.03----
Upgrade
Updated Sep 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q